Liver cirrhosis and portal hypertension in cystic fibrosis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042737-200310000-00002PMID 14501614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

  2002cited by this paper
• Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.

  1999cited by this paper
• Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients.

  1999cited by this paper
• Clinical and Genetic Risk Factors for Cystic Fibrosis-related Liver Disease

  1999cited by this paper
• LIVER TRANSPLANTATION IN CYSTIC FIBROSIS

  1999cited by this paper
• Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group.

  1999cited by this paper
• Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.

  1998cited by this paper
• Management of esophageal varices in children by endoscopic variceal ligation.

  1996cited by this paper
• The treatment of portal hypertension: A meta‐analytic review

  1995cited by this paper
• Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience.

  1995cited by this paper
• Liver transplantation for hepatic cirrhosis in cystic fibrosis.

  1994cited by this paper
• Analysis of risk factors for the development of liver disease associated with cystic fibrosis.

  1994cited by this paper
• Decompression of portal hypertension in a child with cystic fibrosis after transjugular intrahepatic portosystemic shunt placement.

  1994cited by this paper
• Hepatobiliary Disease in Cystic Fibrosis

  1994cited by this paper
• Complications and limitations of injection sclerotherapy in portal hypertension.

  1993cited by this paper
• Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

  1993cited by this paper
• Liver cirrhosis in cystic fibrosis.

  1993cited by this paper
• Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis.

  1992cited by this paper
• Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease.

  1992cited by this paper
• Genotype analysis for ΔF508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease

  1992cited by this paper
• Endoscopic sclerotherapy in the management of gastric variceal haemorrhage.

  1991cited by this paper
• Prevalence of liver disease in cystic fibrosis.

  1991cited by this paper
• Liver transplantation in cystic fibrosis.

  1989cited by this paper
• Management of variceal hemorrhage in the potential liver transplant candidate.

  1989cited by this paper
• Controversies in the management of bleeding esophageal varices (2)

  1989cited by this paper
• Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial

  1985cited by this paper
• FAILURE OF REPEATED INJECTION SCLEROTHERAPY TO IMPROVE LONG-TERM SURVIVAL AFTER OESOPHAGEAL VARICEAL BLEEDING: A Five-year Prospective Controlled Clinical Trial

  1983cited by this paper
• Hepatic complications of cystic fibrosis.

  1981cited by this paper
• The management of portal hypertension in cystic fibrosis.

  1977cited by this paper
• Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic hunting.

  1976cited by this paper

• Imaging of cystic fibrosis manifestations in the abdomen

  2024cites this paper
• Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations

  2024cites this paper
• Cystic Fibrosis in an Adolescent: A “Miranda Warning” Against Blaming TB—A Case-Based Scholarly Update

  2024cites this paper
• Clinical and genetic risk factors for cystic fibrosis‐related liver disease in Egyptian CF children: A single‐center experience

  2023influential citation
• Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations

  2023cites this paper
• Interventions for preventing and managing advanced liver disease in cystic fibrosis.

  2020cites this paper
• Encephalopathy in cystic fibrosis.

  2020cites this paper
• Hospitalization Costs of Canadian Cystic Fibrosis Patients

  2020cites this paper
• Hepatobiliary Involvement in Cystic Fibrosis

  2020cites this paper
• Cystic fibrosis-associated liver disease in children.

  2020cites this paper
• Cystic Fibrosis And Liver Disease

  2020cites this paper
• Microgallbladder: Self-Remitting Acute Cholecystitis-Like Condition Unique to Patients with Cystic Fibrosis

  2019cites this paper
• Screening and Dental Management with the Cystic Fibrosis in North Macedonia

  2019cites this paper
• Cystic fibrosis and portal hypertension: Distal splenorenal shunt can prevent the need for future liver transplant.

  2019cites this paper
• Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis

  2019cites this paper
• Liver Changes in the Course of Cystic Fibrosis

  2019cites this paper
• Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients

  2018cites this paper
• Imaging the Abdominal Manifestations of Cystic Fibrosis

  2017cites this paper
• Correlation of Transient Elastography With Severity of Cystic Fibrosis–related Liver Disease

  2017cites this paper
• Interventions for preventing and managing advanced liver disease in cystic fibrosis.

  2017cites this paper
• Interventions for managing advanced liver disease in cystic fibrosis

  2016cites this paper
• Severe liver dysfunction in an infant with cystic fibrosis masquerading as metabolic liver disease

  2016cites this paper
• 47 – Cystic Fibrosis

  2016cites this paper
• Bisdemethoxycurcumin Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2

  2015cites this paper
• Nutrition and Cystic Fibrosis Related Liver Disease

  2015cites this paper
• Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis

  2015cites this paper
• Cholestasis and meconium ileus in infants with cystic fibrosis and their clinical outcomes

  2014cites this paper
• The liver in pediatric gastrointestinal disease.

  2014cites this paper
• Cholestatic liver disease.

  2014cites this paper
• Cholestasis Related to Systemic Disorders

  2014cites this paper
• Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities

  2014cites this paper
• Liver disease in cystic fibrosis.

  2014cites this paper
• Metabolic Liver Disease: Part 2

  2014cites this paper
• Cirrhosis and other liver disease in cystic fibrosis.

  2013influential citation
• Serum and urinary carnitine in children with cystic fibrosis

  2013cites this paper
• Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease

  2013cites this paper
• Gastrointestinal manifestations of cystic fibrosis in the pediatric patient: an imaging exhibit from the fetus to the young adult

  2013cites this paper
• A grading scheme for liver parenchymal appearances in cystic fibrosis on ultrasonography Grade Appearance N Normal I Increased liver echogenicity II Slight subjective coarsening of liver echo texture III Definite coarsening , no nodularity IV Parenchymal distortion / nodularity

  2013cites this paper
• Imaging Cystic Fibrosis : A Case Study

  2013cites this paper
• TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression

  2013cites this paper
• Ursodeoxycholic acid therapy in cystic fibrosis liver disease – a retrospective long‐term follow‐up case‐control study

  2012cites this paper
• Pulmonary function in individuals who underwent liver transplantation: From the US cystic fibrosis foundation registry

  2012cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS PNEUMOLÓGICAS

  2012cites this paper
• Quantitative morphologic assessment of the newborn cystic fibrosis pig tracheal lobe

  2012cites this paper
• Experimental studies and clinical experiences on treatment of secondary hypersplenism with extracorporeal high-intensity focused ultrasound.

  2012cites this paper
• Liver transplantation in chronic cholestatic conditions.

  2012cites this paper
• Ultrasonography and magnetic resonance imaging findings of abdominal complications of cystic fibrosis.

  2012cites this paper
• Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

  2011cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS PNEUMOLÓGICAS

  2011cites this paper
• Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay

  2010cites this paper
• The clinical and laboratory manifestations of Iranian patients with cystic fibrosis.

  2010cites this paper
• Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.

  2010cites this paper
• Isolated liver transplantation in children with cystic fibrosis – An Australian experience

  2010cites this paper
• Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.

  2010cites this paper
• Genes and Nutrition

  2010cites this paper
• Diffuse Parenchymal Disease

  2008cites this paper
• Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.

  2008cites this paper
• Relation between Fatty Acid Composition and Clinical Status or Genotype in Cystic Fibrosis Patients

  2008cites this paper
• A Case of Idiopathic Portal Hypertension in a 3-year-old Girl

  2007cites this paper
• Emergency embolization of multiple splenic artery pseudoaneurysms associated with portal hypertension complicating cystic fibrosis.

  2007cites this paper
• The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid

  2007cites this paper
• Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases

  2007cites this paper
• Outcome of total splenectomy with portosystemic shunt for massive splenomegaly and variceal bleeding in cystic fibrosis.

  2006influential citation
• Review of the abdominal manifestations of cystic fibrosis in the adult patient.

  2006cites this paper
• Hepatobiliary disorders.

  2006cites this paper
• Biliary liver cirrhosis secondary to cystic fibrosis: a rare indication for liver transplantation.

  2006cites this paper
• Sonographie extrapulmonaler Befunde bei Kindern und Jugendlichen mit zystischer Fibrose

  2006cites this paper
• The gallbladder and biliary tract in cystic fibrosis

  2005cites this paper
• [Liver transplantation for metabolic liver disease in adulthood].

  2004cites this paper
• Hepatobiliary complications of cystic fibrosis

  2004cites this paper
• Lebertransplantation bei metabolischen Lebererkrankungen im Erwachsenenalter

  2004cites this paper
• Acyl CoA: Diacylglycerol acyltransferases (DGATs) as therapeutic targets for cardiovascular disease

  2003cites this paper